The activist says he has recently purchased a large stake in Allergan, which in April called off its $150 billion pact with Pfizer.

Jim Cramer says the antitrust environment out there will make it difficult for any railroad mergers to be approved by regulators.

Investors are gearing up for another assessment of the global economy, as the Fed Prepares to release the minutes of its March meeting.

The latest rules are seen likely to prompt a rethink of the $150 billion pharmaceuticals deal.

Jim Cramer says the merger between Pfizer and Allergan isn't going anywhere, as lawmakers try to limit corporate inversions.

TheStreet's Jim Cramer said Valeant Pharmaceuticals' (VRX) move to appoint billionaire investor Bill Ackman to the board of directors isn't enough and a government monitor is needed.

Despite the financial hardships plaguing some economies, healthcare M&A is still on the rise and experts indicate there is no sign of it slowing.

TheStreet highlights 3 stocks pushing the drugs industry higher today.

The Botox maker now has complete 'facial domination,' Cramer says.

People who are traveling by air are about to see a change in recent trends.

Beverage giant is rolling out a new taste in its efforts to attract and keep a key demographic.

You can find savings on everything from EVs to solar panels in the Inflation Reduction Act.